New thoughts on the pathophysiology of osteoarthritis: One more step toward new therapeutic targets
Authors:
- Johanne Martel-PelletierJMJohanne Martel-Pelletier
- Daniel LajeunesseDLDaniel Lajeunesse
- Hassan FahmiHFHassan Fahmi
- Ginette TardifGTGinette Tardif
- Jean-Pierre PelletierJPJean-Pierre Pelletier
- 1 February 2006
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 8 (1) , 30-36
Abstract
Osteoarthritis is considered an illness in which a complex interaction between the tissues of the joint plays a significant role in the initiation and/or progression of this pathophysiology. We do not yet completely understand all the factors that are responsible for initiating the degradation and loss of the articular tissues. This paper summarizes the novelties of three such mechanisms. The first one points to some factors involved in the regulation of one growth factor family, the bone morphogenetic proteins, the second, the regulation of prostaglandin E2 synthesis, and the third the factors involved in subchondral bone remodeling, all of which could be very significant events for osteoarthritis. This paper should help the reader better understand the most recent advances regarding the roles of these factors in this disease process, and how new therapeutic targets may be identified.Keywords
This publication has 51 references indexed in Scilit:
- Is progressive osteoarthritis an atheromatous vascular disease?Annals of the Rheumatic Diseases, 2005
- The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrowOsteoarthritis and Cartilage, 2005
- Haplotypes of the low-density lipoprotein receptor-related protein 5 (LRP5) gene: Are they a risk factor in osteoarthritis?Osteoarthritis and Cartilage, 2005
- A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophyOsteoarthritis and Cartilage, 2005
- Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synoviumArthritis & Rheumatism, 2004
- A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilageDevelopment, 2004
- Nanomechanical properties and mineral concentration in articular calcified cartilage and subchondral boneJournal of Anatomy, 2003
- Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic kneesOsteoarthritis and Cartilage, 2003
- Bone Morphogenetic Protein-Mediating Receptor-Associated Smads as well as Common Smad Are Expressed in Human Articular Chondrocytes but not Up-Regulated or Down-Regulated in Osteoarthritic CartilageJournal of Bone and Mineral Research, 2002
- Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosisAnnals of the Rheumatic Diseases, 1997